SAN DIEGO , Nov. 15, 2025 /PRNewswire/ -- BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego, highlighting new breakthroughs in human iPSC-derived cell models and regenerative neuroscience.

These presentations underscore BrainXell's focus on scientific discovery and clinical translation, spanning scalable cell-based assays, advanced disease modeling, and next-generation cell therapies for neurodegenerative disorders.

Dr. Su-Chun Zhang, BrainXell Founder and Advising CSO, states, "BrainXell is at the forefront of the biotechnology industry, engineering novel cellular platforms for biomedical discovery and pharmaceutical development, as well as developing personalized regenerative ther

See Full Page